STAC3
protein-codingSH3 and cysteine rich domain 3
Gene summary
The protein encoded by this gene is a component of the excitation-contraction coupling machinery of muscles. This protein is a member of the Stac gene family and contains an N-terminal cysteine-rich domain and two SH3 domains. Mutations in this gene are a cause of Native American myopathy. [provided by RefSeq, Nov 2013]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009722
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009722
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009722
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009722
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009722
Submitter: ClinGen
STAC3 was first reported in relation to autosomal recessive Bailey-Bloch congenital myopathy in 2013 (Horstick EJ, et al., 2013, PMID: 23736855). At least nine unique variants (e.g. missense, nonsense, frameshift, and intronic) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene have been reported in at least 20 probands in four publications (PMIDs:28411587, 23736855, 28777491, 30168660). Variants in this gene segregated with disease in eight additional family members. This gene-disease association is supported by its biochemical function in myoblast differentiation (PMID: 24788338), its expression in skeletal muscle (PMID: 23626854), and animal models in both zebrafish (PMID: 23736855) and mice (PMID: 23626854). In summary, STAC3 is definitively associated with autosomal recessive Bailey-Bloch congenital myopathy.
Inheritance Pattern: AR
Disease ID:MONDO:0009722
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal
Intervention: Musculoskeletal; Pharmacogenomic
Rationale: Among other findings, individuals have been described with susceptibility to malignant hyperthermia related to anesthesia, and awareness may allow preventive measures
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to STAC3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_145064.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 52 | 1 | 55 | ||
| missense | 1 | 119 | 3 | 1 | 124 | |
| nonsense | 3 | 2 | 2 | 7 | ||
| start loss | 0 | |||||
| frameshift | 5 | 3 | 1 | 9 | ||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 6 | 10 | ||
| Total | 9 | 9 | 130 | 55 | 2 | 205 |
Highest pathogenic variant AF is 0.000064427644
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_659501.1 | 11 | MANE Select | |
| Ensembl | ENSP00000329200.2 | 11 | MANE Select | |
| RefSeq | NP_001273185.1 | 10 | Standard | |
| RefSeq | NP_001273186.1 | 7 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| stac3 | Danio rerio | Structure: fast muscle cell Quality: process quality abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- skeletal muscle contraction
- neuromuscular synaptic transmission
- intracellular signal transduction
- skeletal muscle fiber development
- positive regulation of voltage-gated calcium channel activity
Molecular Function
- protein binding
- identical protein binding
- metal ion binding
Cellular Component
- nucleoplasm
- cytosol
- voltage-gated calcium channel complex
- extrinsic component of cytoplasmic side of plasma membrane
- sarcolemma
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000332782
- Coding exons
- 11
- Length
- 7741
- Individuals with no LoFs
- 125693
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 55
- Defined
- 125748
- p
- 0.000219
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.906 | 180 | 218 | 0.827 | 0.0000122 | 2405 |
| Missense (PolyPhen) | 76 | 84.692 | 0.89737 | 892 | ||
| Synonymous | 1.26 | 62 | 75.9 | 0.817 | 0.00000398 | 652 |
| Loss of Function | 2.44 | 10 | 22.5 | 0.445 | 0.00000122 | 256 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00050 | 0.00049 | rare |
| Latino/Admixed American | 0.00032 | 0.00032 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00023 | 0.00023 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Required for normal excitation-contraction coupling in skeletal muscle and for normal muscle contraction in response to membrane depolarization. Required for normal Ca(2+) release from the sarcplasmic reticulum, which ultimately leads to muscle contraction. Probably functions via its effects on muscle calcium channels (PubMed:23736855, PubMed:29078335). Increases CACNA1S channel activity, in addition to its role in enhancing the expression of CACNA1S at the cell membrane. Has a redundant role in promoting the expression of the calcium channel CACNA1S at the cell membrane (By similarity). Slows down the inactivation rate of the calcium channel CACNA1C (PubMed:29078335). {ECO:0000250|UniProtKB:Q8BZ71, ECO:0000269|PubMed:23736855, ECO:0000269|PubMed:29078335}.;
- Disease
- DISEASE: Native American myopathy (NAM) [MIM:255995]: A disease characterized by congenital weakness and arthrogryposis, cleft palate, ptosis, short stature, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia provoked by anesthesia. {ECO:0000269|PubMed:23736855, ECO:0000269|PubMed:29078335}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- LoFtool
- 0.420
- RVIS EVS
- -0.14
- RVIS percentile EVS
- 43.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.758
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |